Navigation Links
THE PLANNING SHOP international Announces Oncology Business Unit

PHILADELPHIA and LONDON, June 30 /PRNewswire/ -- THE PLANNING SHOP international (TPSi) is pleased to announce the launch of its new Oncology Business Unit (OBU) which will be fully dedicated to the oncology therapeutic area. This announcement was made at the European Pharmaceutical Market Research Association (EphMRA) Conference, which was held June 22-24, 2010, in Berlin, Germany.

Oncology is a complex, fast moving therapeutic area.  Numerous pharmaceutical products are currently approved or under development for the treatment of more than 200 different types of cancer.  Conducting oncology market research is challenging because it is difficult to find a marketing research agency that truly understands the therapeutic area as well as the brand implications of various investigational and marketed pharmaceutical products.  The TPSi OBU consists of a team that is fully dedicated to oncology projects and is led by market research professionals who are experts in both the therapeutic area and the relevant associated brands. Leading the OBU is Kelly Price, who has spent eight years working in both syndicated and customized oncology research in Japan, China, throughout Asia Pacific, and most recently in the United States.

"TPSi is delighted to welcome Kelly Price to head up its new Oncology Business Unit," said Kim Hughes, Managing Director, TPSi London.  "Her joining TPSi represents the merger of deep oncology therapy knowledge with broad brand understanding, the synergies of which will provide clients with brand strategy for a fast-shifting clinical context."

The TPSi Oncology Business Unit was established when the company recognized that most of its clients were increasingly involved in oncology -- either marketing existing compounds or developing new compounds.  According to Sherry Fox, President, TPSi North America and founder of the unit, "We recognized the need for a dedicated division focused on oncology, so we set out to find a leader who  would contribute the necessary expertise.  Many of our clients are specifically asking for this level of oncology knowledge, which combined with our brand strategy experience will provide a complete solution to oncology marketing research needs."  

About THE PLANNING SHOP international

THE PLANNING SHOP international was established in 1987 as a strategic brand consultancy.  The company quickly expanded into market research and the pharmaceutical industry in particular, on which it now focuses 100% of its efforts.  The organization's unique brand-building market research products, delivered through branding and consultancy experience, makes TPSi unique in the pharmaceutical market research sector.  Constantly innovating by using new techniques, TPSi is committed to helping its clients build superior brands from Phase 2 to in-market.  With offices in London, Brussels, and Philadelphia, TPSi focuses on brand strategy in addition to market research, working on behalf of clients around the globe.  

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
2. ClearTrial Launches New Service to Bring Speed and Accuracy in Clinical Trial Planning Within Reach of Smaller Biopharma Companies
3. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
4. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
5. Centage Corporation Announces Planning Maestro Business Performance Management Software for Mid-Market Enterprises
6. Varian Medical Systems Acquires Assets of IKOEmed and IKOEtech; Acquisition to Add Software for Accelerating Radiotherapy Treatment Planning
7. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
8. Nucletron Releases Comprehensive Film-and Volume-Based Planning System for Wide Variety of Brachy Solutions
9. Oregon Health & Science University Knight Cancer Institute Enhances Patient Care With Monaco(R) Radiation Treatment Planning System
10. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
11. 10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... ... that includes over 2,000 technical presentations offered in symposia, oral sessions, workshops, ... applied spectroscopy, covers a wide range of applications such as, but not limited ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/24/2015)... 2015  Asia-Pacific (APAC) holds the third-largest share ... The trend of outsourcing to low-cost locations is ... volume share for the region in the short ... in the CRO industry will improve. ... ), finds that the market earned revenues ...
Breaking Biology Technology:
(Date:11/20/2015)... 2015 NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... was recently interviewed on The RedChip Money Report ... weekend on Bloomberg Europe , Bloomberg Asia, Bloomberg ... NXTD ) ("NXT-ID" or the "Company"), a biometric ...
(Date:11/18/2015)... , November 18, 2015 ... published a new market report titled  Gesture Recognition Market ... Forecast, 2015 - 2021. According to the report, the global gesture ... is anticipated to reach US$29.1 bn by 2021, at ... North America dominated the global ...
(Date:11/17/2015)... Nov. 17, 2015 Pressure BioSciences, Inc. (OTCQB: ... development and sale of broadly enabling, pressure cycling technology ... industry, today announced it has received gross proceeds of ... Private Placement (the "Offering"), increasing the total amount raised ... more additional closings are expected in the near future. ...
Breaking Biology News(10 mins):